2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Iodide modulates protein damage induced by the inflammation-associated heme enzyme myeloperoxidase

      research-article
      a , a , a , b , c , a ,
      Redox Biology
      Elsevier
      Myeloperoxidase, Iodide, Inflammation, Fibronectin, Hypochlorous acid, 3-Chlorotyrosine, 3-ClTyr, 3-chlorotyrosine, DPBS, Dulbecco's phosphate-buffered saline, ECM, extracellular matrix, HCAEC, human coronary artery endothelial cells, HOCl, the physiological mixture of hypochlorous acid and its anion –OCl, LC-MS, liquid chromatography-mass spectrometry, mAb, monoclonal antibody, MPO, myeloperoxidase, MS, mass spectrometry, MSA, methanesulfonic acid, OPA, o-phthaldialdehyde, PBS, phosphate-buffered saline, PBST, phosphate-buffered saline with added Tween 20, TBS, Tris-buffered saline, TBST, Tris-buffered saline with added Tween 20, TCA, trichloroacetic acid, TFA, trifluoroacetic acid

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Iodide ions (I ) are an essential dietary mineral, and crucial for mental and physical development, fertility and thyroid function. I is also a high affinity substrate for the heme enzyme myeloperoxidase (MPO), which is involved in bacterial cell killing during the immune response, and also host tissue damage during inflammation. In the presence of H 2O 2 and Cl , MPO generates the powerful oxidant hypochlorous acid (HOCl), with excessive formation of this species linked to multiple inflammatory diseases. In this study, we have examined the hypothesis that elevated levels of I would decrease HOCl formation and thereby protein damage induced by a MPO/Cl /H 2O 2 system, by acting as a competitive substrate. The presence of increasing I concentrations (0.1–10 μM; i.e. within the range readily achievable by oral supplementation in humans), decreased damage to both model proteins and extracellular matrix components as assessed by gross structural changes (SDS-PAGE), antibody recognition of parent and modified protein epitopes (ELISA), and quantification of both parent amino acid loss (UPLC) and formation of the HOCl-biomarker 3-chlorotyrosine (LC-MS) (reduced by ca. 50% at 10 μM I ). Elevated levels of I ( > 1 μM) also protected against functional changes as assessed by a decreased loss of adhesion (eg. 40% vs. < 22% with >1 μM I ) of primary human coronary artery endothelial cells (HCAECs), to MPO-modified human plasma fibronectin. These data indicate that low micromolar concentrations of I , which can be readily achieved in humans and are readily tolerated, may afford protection against cell and tissue damage induced by MPO.

          Graphical abstract

          Highlights

          • Iodide ions (I-) are an essential dietary mineral and critical to biological function.

          • Myeloperoxidase (MPO)-derived oxidants are bactericidal, but also damage host tissue.

          • Levels can be readily elevated in humans and animals by supplementation.

          • Is a high affinity substrate for MPO and acts as a competitive substrate.

          • Decreases MPO-mediated damage to model proteins and extracellular matrix species.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          Iodine-deficiency disorders.

          2 billion individuals worldwide have insufficient iodine intake, with those in south Asia and sub-Saharan Africa particularly affected. Iodine deficiency has many adverse effects on growth and development. These effects are due to inadequate production of thyroid hormone and are termed iodine-deficiency disorders. Iodine deficiency is the most common cause of preventable mental impairment worldwide. Assessment methods include urinary iodine concentration, goitre, newborn thyroid-stimulating hormone, and blood thyroglobulin. In nearly all countries, the best strategy to control iodine deficiency is iodisation of salt, which is one of the most cost-effective ways to contribute to economic and social development. When iodisation of salt is not possible, iodine supplements can be given to susceptible groups. Introduction of iodised salt to regions of chronic iodine-deficiency disorders might transiently increase the proportion of thyroid disorders, but overall the small risks of iodine excess are far outweighed by the substantial risks of iodine deficiency. International efforts to control iodine-deficiency disorders are slowing, and reaching the third of the worldwide population that remains deficient poses major challenges.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Myeloperoxidase and cardiovascular disease.

            Myeloperoxidase (MPO) is a leukocyte-derived enzyme that catalyzes the formation of a number of reactive oxidant species. In addition to being an integral component of the innate immune response, evidence has emerged that MPO-derived oxidants contribute to tissue damage during inflammation. MPO-catalyzed reactions have been attributed to potentially proatherogenic biological activities throughout the evolution of cardiovascular disease, including during initiation, propagation, and acute complication phases of the atherosclerotic process. As a result, MPO and its downstream inflammatory pathways represent attractive targets for both prognostication and therapeutic intervention in the prophylaxis of atherosclerotic cardiovascular disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds.

              Hypochlorous acid (HOCl) is a potent oxidant, which is produced in vivo by activated phagocytes. This compound is an important antibacterial agent, but excessive or misplaced production has been implicated in a number of human diseases, including atherosclerosis, arthritis, and some cancers. Proteins are major targets for this oxidant, and such reaction results in side-chain modification, backbone fragmentation, and cross-linking. Despite a wealth of qualitative data for such reactions, little absolute kinetic data is available to rationalize the in vitro and in vivo data. In this study, absolute second-order rate constants for the reactions of HOCl with protein side chains, model compounds, and backbone amide (peptide) bonds have been determined at physiological pH values. The reactivity of HOCl with potential reactive sites in proteins is summarized by the series: Met (3.8 x 10(7) M(-1) x s(-1)) > Cys (3.0 x 10(7) M(-1) x s(-1)) > cystine (1.6 x 10(5) M(-1) x s(-1)) approximately His (1.0 x 10(5) M(-1) x s(-1)) approximately alpha-amino (1.0 x 10(5) M(-1) x s(-1)) > Trp (1.1 x 10(4) M(-1) x s(-1)) > Lys (5.0 x 10(3) M(-1) x s(-1)) > Tyr (44 M(-1) x s(-1)) approximately Arg (26 M(-1) x s(-1)) > backbone amides (10-10(-3) M(-1) x s(-1)) > Gln(0.03 M(-1) x s(-1)) approximately Asn (0.03 M(-1) x s(-1)). The rate constants for reaction of HOCl with backbone amides (peptide bonds) vary by 4 orders of magnitude with uncharged peptide bonds reacting more readily with HOCl than those in a charged environment. These kinetic parameters have been used in computer modeling of the reactions of HOCl with human serum albumin, apolipoprotein-A1 and free amino acids in plasma at different molar excesses. These models are useful tools for predicting, and reconciling, experimental data obtained in HOCl-induced oxidations and allow estimations to be made as to the flux of HOCl to which proteins are exposed in vivo.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                20 September 2019
                January 2020
                20 September 2019
                : 28
                : 101331
                Affiliations
                [a ]Dept. of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
                [b ]Faculty of Chemistry, Adam Mickiewicz University, and Wielkopolska Center for Advanced Technologies Poznan, Poland
                [c ]Marine Biological Section, Department of Biology, University of Copenhagen, Denmark
                Author notes
                []Corresponding author. davies@ 123456sund.ku.dk
                Article
                S2213-2317(19)31020-1 101331
                10.1016/j.redox.2019.101331
                6812061
                31568923
                e909ba79-1dde-4ae5-ac75-92cbcbb524f7
                © 2019 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 27 August 2019
                : 10 September 2019
                : 16 September 2019
                Categories
                Research Paper

                myeloperoxidase,iodide,inflammation,fibronectin,hypochlorous acid,3-chlorotyrosine,3-cltyr, 3-chlorotyrosine,dpbs, dulbecco's phosphate-buffered saline,ecm, extracellular matrix,hcaec, human coronary artery endothelial cells,hocl, the physiological mixture of hypochlorous acid and its anion –ocl,lc-ms, liquid chromatography-mass spectrometry,mab, monoclonal antibody,mpo, myeloperoxidase,ms, mass spectrometry,msa, methanesulfonic acid,opa, o-phthaldialdehyde,pbs, phosphate-buffered saline,pbst, phosphate-buffered saline with added tween 20,tbs, tris-buffered saline,tbst, tris-buffered saline with added tween 20,tca, trichloroacetic acid,tfa, trifluoroacetic acid

                Comments

                Comment on this article